Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2004 | 1 |
2010 | 1 |
2011 | 2 |
2012 | 2 |
2014 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Wilms' tumor and neuroblastoma.
Acta Paediatr Suppl. 2004 May;93(445):78-84; discussion 84-5. doi: 10.1111/j.1651-2227.2004.tb03063.x.
Acta Paediatr Suppl. 2004.
PMID: 15176727
Review.
Studying navitoclax, a targeted anticancer drug, in healthy volunteers--ethical considerations and risk/benefit assessments and management.
Xiong H, Pradhan RS, Nada A, Krivoshik AP, Holen KD, Rhodes JW, Gordon GB, Humerickhouse R, Awni WM.
Xiong H, et al. Among authors: krivoshik ap.
Anticancer Res. 2014 Jul;34(7):3739-46.
Anticancer Res. 2014.
PMID: 24982396
Clinical Trial.
Item in Clipboard
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.
Roberts AW, Seymour JF, Brown JR, Wierda WG, Kipps TJ, Khaw SL, Carney DA, He SZ, Huang DC, Xiong H, Cui Y, Busman TA, McKeegan EM, Krivoshik AP, Enschede SH, Humerickhouse R.
Roberts AW, et al. Among authors: krivoshik ap.
J Clin Oncol. 2012 Feb 10;30(5):488-96. doi: 10.1200/JCO.2011.34.7898. Epub 2011 Dec 19.
J Clin Oncol. 2012.
PMID: 22184378
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors.
Gandhi L, Camidge DR, Ribeiro de Oliveira M, Bonomi P, Gandara D, Khaira D, Hann CL, McKeegan EM, Litvinovich E, Hemken PM, Dive C, Enschede SH, Nolan C, Chiu YL, Busman T, Xiong H, Krivoshik AP, Humerickhouse R, Shapiro GI, Rudin CM.
Gandhi L, et al. Among authors: krivoshik ap.
J Clin Oncol. 2011 Mar 1;29(7):909-16. doi: 10.1200/JCO.2010.31.6208. Epub 2011 Jan 31.
J Clin Oncol. 2011.
PMID: 21282543
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.
Rudin CM, Hann CL, Garon EB, Ribeiro de Oliveira M, Bonomi PD, Camidge DR, Chu Q, Giaccone G, Khaira D, Ramalingam SS, Ranson MR, Dive C, McKeegan EM, Chyla BJ, Dowell BL, Chakravartty A, Nolan CE, Rudersdorf N, Busman TA, Mabry MH, Krivoshik AP, Humerickhouse RA, Shapiro GI, Gandhi L.
Rudin CM, et al. Among authors: krivoshik ap.
Clin Cancer Res. 2012 Jun 1;18(11):3163-9. doi: 10.1158/1078-0432.CCR-11-3090. Epub 2012 Apr 11.
Clin Cancer Res. 2012.
PMID: 22496272
Free PMC article.
Clinical Trial.
Item in Clipboard
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.
Wilson WH, O'Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, Tulpule A, Dunleavy K, Xiong H, Chiu YL, Cui Y, Busman T, Elmore SW, Rosenberg SH, Krivoshik AP, Enschede SH, Humerickhouse RA.
Wilson WH, et al. Among authors: krivoshik ap.
Lancet Oncol. 2010 Dec;11(12):1149-59. doi: 10.1016/S1470-2045(10)70261-8. Epub 2010 Nov 18.
Lancet Oncol. 2010.
PMID: 21094089
Free PMC article.
Clinical Trial.
Item in Clipboard
Force relaxes before the fall of cytosolic calcium in the photomechanical response of rat sphincter pupillae.
Krivoshik AP, Barr L.
Krivoshik AP, et al.
Am J Physiol Cell Physiol. 2000 Jul;279(1):C274-80. doi: 10.1152/ajpcell.2000.279.1.C274.
Am J Physiol Cell Physiol. 2000.
PMID: 10898739
Free article.
Item in Clipboard
Cite
Cite